Table 4 Chemotherapy regimens received by patients in the cisplatin group
Type of chemotherapy | Number of patients (%) N = 200 |
|---|---|
Cisplatin + Gemcitabine | 58 (29) |
Cisplatin + Concurrent chemoradiation | 28 (14) |
Cisplatin + 5-FU/Cisplatin + Capecitabine | 8 (4) |
Cisplatin + 5-FU + Radiation/Cisplatin + Capecitabine + Radiation | 7 (3.5) |
Docetaxel + Cispaltin + 5-FU | 30 (15) |
Epirubicin + Cisplatin + 5-FU/Epirubicin + Cisplatin | 10 (5) |
Docetaxel + Cispaltin + 5-FU + Cetuximab | 4 (2) |
DHAP (Dexamethasone + High dose ARA-C + Cisplatin) | 8 (4) |
Cisplatin + Etoposide/Cisplatin + Etoposide + Bleomycin | 12 (6) |
Cisplatin + Pemetrexed | 16 (8) |
Cisplatin + Navelbine | 15 (7.5) |
Cispaltin + Gemcitabine + Radiation | 4 (2) |